OR Royalties Insider Trading

Crescita Therapeutics is a Canadian biotechnology company that focuses on the development and commercialization of innovative therapies for skin health and aesthetics. The company was established in 2002, with a commitment to advancing science and improving patient care. Crescita Therapeutics operates with a strong emphasis on research and development, particularly in the fields of dermatology and skincare treatments. Headquartered in Toronto, Ontario, the company has positioned itself as a leader in creating solutions that address a wide range of skin-related conditions, leveraging cutting-edge technology and expertise. Crescita is publicly traded on the Toronto Stock Exchange (TSE) under the ticker symbol “CTX.” With a broad portfolio of intellectual property, the company aims to deliver impactful therapies while advancing dermatological innovation, ensuring its ongoing contribution to the global healthcare landscape. Crescita Therapeutics continues to focus on improving the quality of life for individuals through its products and services.